The results failed to show, however, significant evidence that high-potency statins exert a stronger action on diabetes development than low-potency statins. In summary, this population-based ...
High-dose and high-potency statins did not demonstrate any significant increased risk of rhabdomyolysis. High-dose and high-potency statins did not demonstrate any significant increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback